A B S T R A C T The present study characterized the antibody-dependent cellular cytoxicity (ADCC) of leukocyte effector cells (neutrophils, lymphocytes, and monocytes) from normal subjects and from chronic granulomatous disease (CGD) 
INTRODUCTION
Antibody-dependent cellular cytotoxicity (ADCC)' involves the destruction of sensitized target cells through the interaction of target-specific antisera with effector cell surface Fc receptors (1) . Depending on the type of assay, antibody, target cells, and effector cells employed, the distinct ADCC activities of subpopulations of human leukocytes may vary. Thus, ADCC activity has been reported for neutrophils, monocytes, and Fc receptor-bearing (FcR+) T and non-T lymphocytes (1) . ADCC against antibody-coated human erythrocyte (HRBC) targets in suspension culture has generally been felt to be mediated predominantly by phagocytic cells (i.e., neutrophils and monocytes) (2) . As such, this assay system may primarily reflect postphagocytic intracellular lysis oftarget cells. Conversely, extracellular lysis is the predominant mode of cell killing when antibody-coated nucleated nonerythroid target cells are employed (1) .
The relative contribution of intracellular and extracellular events in ADCC in suspension culture are unclear. Additionally, the mechanisms of these two different modes of cytolysis as well as their potential interrelationship are presently speculative. In an attempt to further delineate the potential mechanisms of ADCC, the present study employed leukocytes from normal subjects and from patients with chronic granulomatous disease (CGD) as effector cells in ADCC assays against HRBC targets in suspension, autologous lymph-oid cell targets in suspension, and HRBC targets in monolayers. Phagocytic cells from CGD patients are deficient in NADPH oxidase activity and consequently lack phagocytosis-induced hydrogen peroxide (H202) and superoxide (O°) generation (3) (4) (5) . We therefore used effector cells from these patients as investigative cellular probes in an attempt to delineate the importance of H202 and°2 and related mechanisms in intracellular and extracellular ADCC activity.
METHODS
Subjects. Peripheral venous blood was obtained from 20 normal adult donors. Four patients with CGD were studied: three male ages 11 (patient 4), 13 (patient 1), and 21 (patient 2), and one female (patient 3), age '15. These patients fulfilled the previously described criteria for the clinical and laboratory diagnosis of CGD (6, 7) . Each of the patients studied showed no nitroblue tetrazolium reduction-upon stimulation with latex particles (8) . In addition, all patients were incapable of generating O2 as monitored by modification of the ferricytochrome c reduction assay (9) using ionophore A23187 and the chemoattractant f-Met-Leu-Phe (1 /AM) ( In this formula the supermatant counts per minute is multiplied by two because the counts per minute of only one-half of the total supernatant is determined. In all cases, spontaneous release was <13%.
Suspension assays using TNP-modified HRBC targets were performed slightly differently. Briefly, 0.7-1.0 x 106 51Cr-labeled TNP-HRBC were pipetted into individual wells to which either 1 x 106 neutrophils, 1 x 106 mononuclear cells (for monocyte-specific ADCC), or 2 x 106 lymphocytes were added. As required, 10 ,l of the appropriate antibody was added to each well. Plates were incubated at 37°C for 3 h and the radioactivity determined for one-half the supernatant. For these experiments, spontaneous release was always <10%.
For assays using target cells in monolayer, microtiter wells were coated with 25 ,ul of sheep IgG anti-TNP antibody for 15 min at 25°C and washed with water. 100 ,l of a 4% suspension ofTNP-modified intact 5lCr-labeled HRBC were then added to each well. After centrifugation, each well was washed five to seven times with balanced salt suspension Hepes and adherent target cells were observed under phase microscopy to verify a dense monolayer of targets. The desired number of effector cells and the appropriate antibody were then added to each well. After incubation at 37°C for 3 h, plates were centrifuged and 100 ,l of supernatant were removed from each well and the determinations of 51Cr release were performed.
For suspension ADCC against 51Cr-labeled rabbit IgG ALS-coated autologous lymphoid cell targets, 106, 105, or 104 effector cells were pipetted into microtiter wells containing 104 target cells. Spontaneous release was determined as described above and was <20% in all cases. Cultures were incubated at 37°C in 5% CO2 in air at 100% humidity for 4 h. Plates were then centrifuged and the percent cytotoxicity (or percent 51Cr release) was determined.
In some experiments, colchicine (Sigma Chemical Co., St. Louis, Mo.) was added to the mixture of effector and target cells at the initiation of culture.
Statistical methods. Data were compared by the Student's two-tailed t test.
RESULTS
ADCC activity against HRBC targets in suspension.
In suspension assays, unfractionated mononuclear cells from normal individuals mediated significant ADCC activity against HRBC targets coated with a 10-1 dilution of rabbit IgG anti-HRBC antisera at an E:T ratio of 100:1 (Fig. 1) . However, mononuclear cells from CGD patients had markedly diminished ADCC activity against these same targets under the same conditions (P < 0.001 for all) (Fig. 1 ). This depression of CGD ADCC responses remained constant regardless of the E:T ratio (Fig. 2) or the concentration of rabbit IgG anti-HRBC antibody employed (data not shown). Additionally, when this activity was assayed at 1, 2, 4, 6, or 12 h after initiation of culture, CGD mononuclear cell effector capabilities remained depressed relative to normal mononuclear effector cells (data not shown). When mononuclear cell suspensions from normal subjects were depleted of monocytes to <1% by passage over Sephadex G-10 columns (Pharmacia Fine Chemicals, Inc.), ADCC activity against HRBC targets in suspension fell from 45+6 to 7+4% (P < 0.001). Presumably the remaining ADCC activity was mediated by nonphagocytic, FcR+ lymphocytes (i.e., T cells and null cells). When mononuclear cell suspensions from pa- FIGURE 1 ADCC activity of normal and CGD mononuclear cells against rabbit IgG anti-HRBC-coated HRBC targets in suspension. At 100:1 E:T ratios, CGD mononuclear effector cells had markedly diminished ADCC activity when compared to normal mononuclear cells. Normal results were compiled from 11 separate experiments with different subjects. CGD patients 1-3 were studied on three separate occasions, whereas patient 4 was studied once. tient 2 were depleted of monocytes, ADCC against HRBC targets fell insignificantly from 16±3 to 6+4% (P < 0.1). However, this value for killing by monocytedepleted CGD mononuclear cells is comparable to that mediated by normal monocyte-depleted mononuclear cells (P < 0.2). Thus, nonphagocytic, FcR+ CGD lymphocytes are capable of extracellular lysis of antibody-coated HRBC comparable to that observed with normal lymphocytes. When the monocyte-specific ADCC ofpatient 2 was additionally determined against human IgG anti-blood group B, antibody-coated, TNPmodified HRBC targets in suspension, 12% specific 51Cr release was observed as compared to 54% 51Cr release mediated by monocytes from a normal subject. With rabbit IgG anti-HRBC antisera, normal neutrophils induced substantial 51Cr release from antibodycoated HRBC targets in suspension (Fig. 3) . However, CGD neutrophils were incapable of significant target cell lysis when compared to normal subjects (P < 0.001 for all) (Fig. 3) . This depression of neutrophil-mediated ADCC was constant regardless of E:T ratios, (Fig. 4) dilution ofantisera, or time of culture interval (0.5-6 h). When neutrophils from patient 2 were additionally assayed against antibody-coated, TNP-modified HRBC target cells in suspension, 14% 51Cr release was observed compared to 68% 51Cr release induced by neutrophils from a normal subject.
Mechanisms of Antibody-dependent Cellular Cytotoxicity (Fig. 6B) . lmM-0.1 ,uM colchicine did not increase the spontaneous release of 5'Cr-labeled HRBC.
When 1 ,uM colchicine was added to TNP-modified HRBC targets in monolayer, no significant enhancement of ADCC was observed with neutrophils from either patient 2 or a normal subject (Fig. 7) . However, using TNP-modified HRBC targets in suspension, 1 ,uM colchicine markedly augmented the neutrophilmediated ADCC of patient 2, but resulted in only a slight increase in the ADCC activity of normal neutrophils. As described above, 1 jiM colchicine alone did not increase the spontaneous release of 51Cr from targets in monolayer.
ADCC activity against lymphoid targets in suspension. With use ofautologous lymphoid targets, we have shown that ADCC activity can be mediated by lymphocytes and neutrophils, but not by monocytes, and that phagocytosis of these targets does not occur.3 As an adjunct to the above studies, we determined that mononuclear cells (Fig. 8) and neutrophils (Fig. 9) from CGD patients killed autologous antibody-coated lymphoid cells normally. These findings remained the same regardless of the E:T ratio, dilution of antibody, or culture interval employed (data not shown).
I Katz, P., and A. S. Fauci. Manuscript in preparation. 
DISCUSSION
The present study has clearly demonstrated that the ADCC activity of human phagocytic cells against antibody-coated human erythrocyte targets in suspension is predominantly an intracellular event that is dependent upon a normal postphagocytic respiratory burst. Normal phagocytes, the predominant effector cells in classic ADCC assays against HRBC targets in suspension (2), could rapidly bind, ingest, and lyse antibody-coated HRBC. CGD phagocytic cells, however, were capable of normal binding and ingestion of these targets but were unable to effect intracellular lysis. Because CGD phagocytes lack the burst of oxidative metabolism that normally occurs during phagocytosis (3) (4) (5) , this would suggest that normal intracellular lysis oferythroid targets is dependent upon this activity.
Because of the findings of abnormal postphagocytic CGD monocyte and neutrophil-mediated ADCC against target cells in suspension, we investigated CGD effector cell capabilities against HRBC targets in monolayer. With this system, antibody-coated HRBC are bound by antibody to plastic surfaces. When exposed to these targets, FcR+ mononuclear cells and neutrophils bind and kill these targets in the absence of phagocytosis.2 By using 5tCr-labeled HRBC targets in monolayer, we have demonstrated that CGD lymphocytes, monocytes, and neutrophils are capable of inducing 51Cr release comparable to that observed when normal effector cells are employed. Thus, CGD effector cells, although incapable of cytotoxic activity against antibody-coated HRBC targets in suspension, can kill these targets normally when they are in monolayer. Conversely, extracellular ADCC, which is mediated normally by CGD effector cells that lack the ability to generate these products, is in all likelihood dependent upon a different metabolic pathway(s).
To date, the exact mechanisms of ADCC activity have been controversial. Clark and Klebanoff (21) using neutrophil effector cells against antibody-coated mammalian tumor cells demonstrated the dependence of this activity on a burst of oxidative metabolism, glycolysis, divalent cations, and microtubular function. CGD effector cells were found by these investigators to have depressed ADCC activity against these targets, thus suggesting the requirement for a metabolic burst. This study as well as that of Fleer et al. (20) suggested that target cell lysis might be dependent upon the extracellular release of the contents of neutrophil and monocyte granules.
Additional studies on the mechanism of ADCC have indicated that this activity was dependent on the maintenance of certain optimal levels of total energy production (22) . Thus, the inhibition of both aerobic and anaerobic energy production totally prevented the lysis of antibody-coated cells of a lymphoblastoid cell line (22) . Studies investigating the mechanism of nonantibody-dependent cytotoxicity have reported conflicting results. MacDonald and Koch (23) have determined that T cell-mediated cytolysis was energy dependent and could be mediated by either glycolytic or oxidative pathways. By using mice macrophages as effector cells, Sorell and co-workers (24) determined that the lysis of allogeneic virus-transformed fibroblasts was not dependent upon the release of either H202 or O-. Conversely, however, three separate studies have indicated that extracellular cytolysis can be mediated by H202 (25) (26) (27) . With effector cells from CGD patients as investigative probes, these studies have indicated that intracellular ADCC is largely a postphagocytic event and as such is dependent upon an intact postphagocytic burst of oxidative metabolism.
Thus, standard ADCC against HRBC targets in suspension may primarily reflect intracellular target lysis. Extracellular target cell lysis, however, appears to be in(lependent of the generation of H202 and/or O2 and additionally may be independent of the action of lysosomal granules. Hlopefully, additional studies in this area will fturther clarify the mechanisms of ADCC.
